VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HMN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HMNHorace Mann Educators Corporation
$53.85$2.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHMNQuarterly Financials

Horace Mann Educators Corporation (HMN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Horace Mann Educators Corporation (HMN) quarterly income statement — complete revenue, gross profit & net income history

HMN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue429.3M419.2M417.1M391.6M400.1M393.1M397.6M379M379.8M384.4M358.2M341.2M349.5M337.6M337.5M332.7M333.7M303.5M312.8M347.1M
Revenue Growth %7.3%6.64%4.9%3.32%5.34%2.26%11%11.08%8.67%13.86%6.13%2.55%4.73%11.24%7.9%-4.15%7.4%-9.76%-4.05%9.01%
Medical Costs & Claims0263M258.2M266.1M265.6M253.5M274.2M288.1M256.2M260.9M278.2M281.3M255.6M273.9M234.1M266.3M236.9M206.4M239.6M221.8M
Medical Cost Ratio %0%62.74%61.9%67.95%66.38%64.49%68.96%76.02%67.46%67.87%77.67%82.44%73.13%81.13%69.36%80.04%70.99%68.01%76.6%63.9%
Gross Profit429.3M156.2M158.9M125.5M134.5M139.6M123.4M90.9M123.6M123.5M80M59.9M93.9M63.7M103.4M66.4M96.8M97.1M73.2M125.3M
Gross Margin %100%37.26%38.1%32.05%33.62%35.51%31.04%23.98%32.54%32.13%22.33%17.56%26.87%18.87%30.64%19.96%29.01%31.99%23.4%36.1%
Gross Profit Growth %219.18%11.89%28.77%38.06%8.82%13.04%54.25%51.75%31.63%93.88%-22.63%-9.79%-3%-34.4%41.26%-47.01%-4.82%-21.83%-25.99%20.13%
Operating Expenses429.3M110.5M87.4M89M87M91.3M80.7M86.3M90.6M76.3M66.4M75.5M85.8M91.9M80M72.4M71.8M47.5M54.2M67.2M
OpEx / Revenue %100%26.36%20.95%22.73%21.74%23.23%20.3%22.77%23.85%19.85%18.54%22.13%24.55%27.22%23.7%21.76%21.52%15.65%17.33%19.36%
Depreciation & Amortization06.7M6.8M6.6M7M7M6.4M6.4M6.6M6.7M6.6M6.3M6.6M6.9M12.8M4.1M3.8M1.7M5.6M5.6M
Combined Ratio %100%89.1%82.86%90.68%88.13%87.71%89.26%98.79%91.31%87.72%96.2%104.57%97.68%108.35%93.07%101.8%92.51%83.66%93.93%83.26%
Operating Income045.7M71.5M36.5M47.5M48.3M42.7M4.6M33M47.2M13.6M-15.6M8.1M-28.2M23.4M-6M25M49.6M19M58.1M
Operating Margin %0%10.9%17.14%9.32%11.87%12.29%10.74%1.21%8.69%12.28%3.8%-4.57%2.32%-8.35%6.93%-1.8%7.49%16.34%6.07%16.74%
Operating Income Growth %-100%-5.38%67.45%693.48%43.94%2.33%213.97%129.49%307.41%267.38%-41.88%-160%-67.6%-156.85%23.16%-110.33%-48.13%-15.3%-57.87%55.35%
EBITDA052.4M78.3M43.1M54.5M55.3M49.1M11M39.6M53.9M20.2M-9.3M14.7M-21.3M36.2M-1.9M28.8M51.3M24.6M63.7M
EBITDA Margin %0%12.5%18.77%11.01%13.62%14.07%12.35%2.9%10.43%14.02%5.64%-2.73%4.21%-6.31%10.73%-0.57%8.63%16.9%7.86%18.35%
Interest Expense010M8.9M8.6M8.9M8.5M8.7M8.7M8.7M8.6M7.5M6.9M6.7M5.9M5.3M4.3M3.9M3.5M3.4M3.5M
Non-Operating Income0-10M-8.9M-8.6M-8.9M-8.5M-8.7M-8.7M-8.7M-8.6M-7.5M-6.9M-6.7M-5.9M-5.3M-4.3M-3.9M-3.5M-3.4M-3.5M
Pretax Income50.2M45.7M71.5M36.5M47.5M48.3M42.7M4.6M33M47.2M13.6M-15.6M8.1M-28.2M23.4M-6M25M49.6M19M58.1M
Pretax Margin %11.69%10.9%17.14%9.32%11.87%12.29%10.74%1.21%8.69%12.28%3.8%-4.57%2.32%-8.35%6.93%-1.8%7.49%16.34%6.07%16.74%
Income Tax9M9.5M13.2M7.1M9.3M10.1M8.4M800K6.5M7.7M1.9M-2.8M1.5M-9.7M3M-1.8M4.7M9.1M2.7M11.4M
Effective Tax Rate %17.93%20.79%18.46%19.45%19.58%20.91%19.67%17.39%19.7%16.31%13.97%17.95%18.52%34.4%12.82%30%18.8%18.35%14.21%19.62%
Net Income41.2M36.2M58.3M29.4M38.2M38.2M34.3M3.8M26.5M39.5M11.7M-12.8M6.6M-18.5M20.4M-4.2M20.3M40.5M16.3M46.7M
Net Margin %9.6%8.64%13.98%7.51%9.55%9.72%8.63%1%6.98%10.28%3.27%-3.75%1.89%-5.48%6.04%-1.26%6.08%13.34%5.21%13.45%
Net Income Growth %7.85%-5.24%69.97%673.68%44.15%-3.29%193.16%129.69%301.52%313.51%-42.65%-204.76%-67.49%-145.68%25.15%-108.99%-48.35%-15.26%-55.34%53.11%
EPS (Diluted)1.000.871.400.710.920.920.830.090.640.950.28-0.310.16-0.400.33-0.300.350.960.391.13
EPS Growth %8.7%-5.43%68.67%688.89%43.75%-3.16%196.43%129.03%300%337.5%-15.15%-3.33%-54.29%-141.67%-15.38%-126.55%-63.16%-16.52%-55.68%54.79%
EPS (Basic)1.000.871.420.710.930.920.830.090.640.960.29-0.310.16-0.400.34-0.300.350.980.391.13
Diluted Shares Outstanding41.2M41.6M41.6M41.6M41.6M41.5M41.4M41.6M41.5M41.5M41.4M41.4M41.4M41.6M41.6M41.8M42.1M42.2M42.2M42.1M